Trump's Tariff Shuffle: 50% Copper Duties, 69 Countries Hit August 7, and Pharma's September Showdown

U.S. President Donald Trump's tariff policies continue to stir up waves across global markets, with several deadline alerts and fresh moves in the weeks ahead drawing attention. His latest decisions are shaking up trade flows and keeping things unpredictable for companies and countries tangled in these disputes.

Recently, the U.S. and the European Union quieted things down a notch by hashing out a trade framework that cuts the threatened import tariff on most EU goods from a whopping 30% to 15%. Given that these two powerhouses handle around a third of global trade, dialing back from a full-blown tariff war was a relief for many. But don't get too comfortable yet-tariff adjustments are still rolling out on imports from other corners, including Canada, Brazil, India, Taiwan, and Switzerland.

Trump didn't stop there. He slapped a 50% tariff on select copper imports and axed the "de minimis" exemption that used to let low-value shipments dodge tariffs. That means starting August 29, packages valued at $800 or less sent through international postal channels will no longer fly under the radar and will face tariffs across the board.

On the pharma front, Trump took a shot across the bow of major drugmakers like Eli Lilly (NYSE: LLY), Pfizer (NYSE: PFE), Novo Nordisk (NYSE: NVO), J&J (NYSE: JNJ), and Merck (NYSE: MRK) by demanding they commit to cutting drug prices in the U.S. They have until September 29 to come back with binding agreements, following an earlier executive order aimed at aligning U.S. drug prices with those overseas.

Amid this ongoing shuffle, here are some key dates to circle:

August 7: "Reciprocal" tariffs are set to kick in against exports from 69 trading partners, with import duties ranging between 10% and 41%. On the geopolitical chessboard, the U.S. said it will begin targeting Russia with tariffs and other measures if Moscow doesn't make headway toward ending the Ukraine conflict.

August 12: The clock runs on the trade truce with China. This is a big one. Trump will decide whether to extend the pause or trigger a tariff ramp-up that could send duties into triple digits, ramping tensions between the world's top two economies and rattling global growth prospects.

August 29: The "de minimis" exemption suspension takes effect. Small packages entering the U.S. outside international postal networks will face the full gamut of tariffs, which could shake up retailers relying on low-value shipments.

September 29: Drugmakers' deadline to respond on cutting medicine prices in the U.S. arrives, keeping them in the spotlight.

Watching the unfolding tariff drama is like following a blockbuster with many sequels yet to come. Whether these moves cool down international frictions or lead to another round of escalations remains to be seen. Meanwhile, market reactions continue to unfold-stocks like Eli Lilly and Pfizer have already felt waves from these trade and pricing developments.